Poly Medicure Ltd Share Price Today - Poly Medicure Ltd Stock Price Live NSE/BSE

Poly Medicure Ltd

NSE: POLYMED BSE: 531768

₹1333.40

(3.88%)

Sun, 15 Mar 2026, 07:41 am

MTF 5xInvest in Poly Medicure Ltd with 5x Leverage Buy with MTF

Market Cap130.32B

PE Ratio38.89

Dividend0.27

Health Technology

Medical Specialties

24.5K

Poly Medicure Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

Market Cap
12778.39
Net Profit
338.56
P/B
8.21
Sector P/E
54.62
P/E
67.11
EV/EBITDA
41.40
Debt/Equity (Industry)
0.28
Interest Cover (Industry)
14.86
ROCE (Industry)
19.47
RONW (Industry)
17.37
ROE
15.99
ROCE
20.24
Debt/Equity
0.08
EPS (TTM)
34.79
Dividend Yield
0.28
Book Value
287.92
Interest Cover
32.60

Analysis

all

Pros

Dividends per share have increased over the past 10 years.
Dividends paid are well covered by earnings (5.4x coverage).
Poly Medicure is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
Poly Medicure is profitable, therefore cash runway is not a concern.
Poly Medicure is profitable, therefore cash runway is not a concern.

Cons

Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
Poly Medicure's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
Poly Medicure's dividend is below the markets top 25% of dividend payers in India (3.08%).
High level of physical assets or inventory.
Himanshu's remuneration is higher than average for companies of similar size in India.

Financials

Ratios

Shareholders	DEC 2025	SEPT 2025	JUN 2025	MAR 2025	DEC 2024
Promoters	62.42	62.42	62.44	62.44	62.44
FII	9.40	9.77	11.41	11.44	12.31
DII	13.84	13.54	11.72	11.96	11.66
Public	14.34	14.27	14.44	14.16	13.59
Government	0	0	0	0	0

Technical Analysis

RSI

39.18

MACD

-45.61

50 DMA

1478.41

200 DMA

1874.78

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	2099.73	1730.43	1493.27	1361.13	1123.97	991.83	622.53
Fibonacci	1730.43	1589.36	1502.21	1361.13	1220.06	1132.91	991.83
Camarilla	1357.66	1323.80	1289.95	1361.13	1222.25	1188.39	1154.54

Pivots Level: Classic

+738.60

2099.73

+369.30

1730.43

+132.13

1493.27

1361.13

Pivot Point

LTP: 1260.20

-237.17

1123.97

-369.30

991.83

-738.60

622.53

Moving Average

SMAEMA

Period

Value

10-EMA
1309.65
20-EMA
1335.27
30-EMA
1375.65
50-EMA
1460.13
100-EMA
1621.05
200-EMA
1809.28

Announcement Date	Purpose	Action	Ex Date
05 Feb 2026	board-meetings	Quarterly Results
08 Nov 2025	board-meetings	Quarterly Results, Half Yearly Results
04 Sept 2025	agm
18 Aug 2025	dividend	Final Dividend - Rs. - 3.5	18 Sept 2025
06 May 2025	dividend	₹3.50 Dividend /Share	18 Sept 2025
10 Sept 2024	agm
19 Aug 2024	dividend	Annual General Meeting/Dividend - Rs 3 Per Share	20 Sept 2024
17 May 2024	dividend	₹3.00 Dividend /Share	20 Sept 2024
06 Sept 2023	agm
21 Aug 2023	dividend	Annual General Meeting/Dividend - Rs 3 Per Share	22 Sept 2023

Poly Medicure Ltd

Narayana Hrudayalaya Ltd

Max Healthcare Institute Ltd

Aster DM Healthcare Ltd

Apollo Hospitals Enterprise Ltd

Fortis Healthcare Ltd

Poly Medicure Ltd About

Poly Medicure is a manufacturer/producer of Medical Devices.

Industry

Healthcare

Founded

1995

Headquarters

CEO

Devendra Raj Mehta

Employees

Contact

Website

http://www.polymedicure.com

cs@polymedicare.com; investorcare@polymedicure.com

Phone

91-11-26321838/81/89/93

Location

Property No 232B 3rd Floor, Okhla Indl Estate Phase-III, New Delhi, New Delhi, 110020

Year	History
2018	Poly Medicure Limited has informed the Exchange regarding 'Intimation of Commencement of Commercial Production'.
2019	Company has been awarded as one of the Top 25 Innovative Companies by CII Industrial Innovation Awards 2019
2020	Poly Medicure Ltd. productivity has increased due to sustained investments in automation. Poly Medicure suggests how India needs to re-strategise a long-term roadmap for promoting the medical devices industry in the post-pandemic era. Poly Medicure to enhance R&D capabilities to deliver high quality medical devices. Poly Medicure Enabling quality primary healthcare through upskilling.
2021	Poly Medicure will make India Atmanirbhar in medical device segment. Poly Medicure Setting Up 2 Plants As Demand Rise.
2022	Poly Medicure Wins India Medical Device Leader of the Year Award 2022 by Government of India.

Client Name	Order Side	QTY	Avg Price	Date
SMALLCAP WORLD FUND INC	Sell	950000	1645	16 Jan 2026
SMALLCAP WORLD FUND INC	Sell	887064	1645	16 Jan 2026
LIGHTHOUSE INDIA III EQUITY INVESTORS LIMITED	Sell	2276269	1950.03	21 Jun 2024
LIGHTHOUSE INDIA III EQUITY INVESTORSLIMITED	Sell	1290939	1550.06	21 Feb 2024
NILAYKUMAR VINODKUMAR DAGA	Buy	600010	228.28	27 Mar 2017
NIRAJKUMAR VINODKUMAR DAGA NRO	Sell	567076	228.35	27 Mar 2017
NIRAJKUMAR VINODKUMAR DAGA NRO	Sell	600000	228.27	27 Mar 2017
NILAYKUMAR VINODKUMAR DAGA	Buy	567066	228.35	27 Mar 2017
NIRAJKUMAR VINODKUMAR DAGA NRO	Sell	400000	248.39	24 Mar 2017
NIRAJKUMAR VINODKUMAR DAGA NRO	Sell	400000	252.05	24 Mar 2017

Poly Medicure Ltd News

Poly Medicure schedules investor meet with Avendus

Poly Medicure Limited announces one-on-one virtual investor meeting with Avendus Spark scheduled for March 19, 2026 at 05:00 PM under SEBI Regulation 30 compliance.

12 Mar 2026

companies

Poly Medicure Shares Updated Investor Presentation

Poly Medicure has shared an updated investor presentation with stock exchanges, highlighting its 15 manufacturing plants and annual capacity of 1.8 billion devices.

07 Mar 2026

stocks

Poly Medicure Reports No QIP Fund Deviation for Q3

Poly Medicure Limited confirms no deviation in utilization of Rs 99,999.98 lakh QIP proceeds for quarter ended December 31, 2025, with funds allocated across manufacturing, acquisitions, and corporate purposes.

13 Feb 2026

stocks

Poly Medicure Q3FY26 Earnings Call on Feb 6, 2026

Poly Medicure Limited announces earnings call on February 6, 2026 at 4:00 PM IST to discuss Q3FY26 and nine months financial results ended December 31, 2025 under SEBI regulations.

31 Jan 2026

co actions results

Poly Medicure Sees ₹157.18 Cr NSE Block Trade

Poly Medicure witnessed a significant NSE block trade worth ₹157.18 crores involving 953,661 shares at ₹1,648.20 per share, indicating substantial institutional activity in the healthcare company's stock.

16 Jan 2026

co actions results

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800